Elsevier

JACC: Heart Failure

Volume 3, Issue 5, May 2015, Pages 408-418
JACC: Heart Failure

Clinical Research
Cardiopulmonary Responses and Prognosis in Hypertrophic Cardiomyopathy: A Potential Role for Comprehensive Noninvasive Hemodynamic Assessment

https://doi.org/10.1016/j.jchf.2014.11.011Get rights and content
Under an Elsevier user license
open archive

Abstract

Objectives

This study sought to discover the key determinants of exercise capacity, maximal oxygen consumption (oxygen uptake [Vo2]), and ventilatory efficiency (ventilation/carbon dioxide output [VE/Vco2] slope) and assess the prognostic potential of metabolic exercise testing in hypertrophic cardiomyopathy (HCM).

Background

The intrinsic mechanisms leading to reduced functional tolerance in HCM are unclear.

Methods

The study sample included 156 HCM patients consecutively enrolled from January 1, 2007 to January 1, 2012 with a complete clinical assessment, including rest and stress echocardiography and cardiopulmonary exercise test (CPET) with impedance cardiography. Patients were also followed for the composite outcome of cardiac-related death, heart transplant, and functional deterioration leading to septal reduction therapy (myectomy or septal alcohol ablation).

Results

Abnormalities in CPET responses were frequent, with 39% (n = 61) of the sample showing a reduced exercise tolerance (Vo2 max <80% of predicted) and 19% (n = 30) characterized by impaired ventilatory efficiency (VE/Vco2 slope >34). The variables most strongly associated with exercise capacity (expressed in metabolic equivalents), were peak cardiac index (r = 0.51, p < 0.001), age (r = –0.25, p < 0.01), male sex (r = 0.24, p = 0.02), and indexed right ventricular end-diastolic area (r = 0.31, p = 0.002), resulting in an R2 of 0.51, p < 0.001. Peak cardiac index was the main predictor of peak Vo2 (r = 0.61, p < 0.001). The variables most strongly related to VE/VCO2 slope were E/E′ (r = 0.23, p = 0.021) and indexed left atrial volume index (LAVI) (r = 0.34, p = 0.005) (model R2 = 0.15). The composite endpoint occurred in 21 (13%) patients. In an exploratory analysis, 3 variables were independently associated with the composite outcome (mean follow-up 27 ± 11 months): peak Vo2 <80% of predicted (hazard ratio: 4.11; 95% confidence interval [CI]: 1.46 to 11.59; p = 0.008), VE/Vco2 slope >34 (hazard ratio: 3.14; 95% CI: 1.26 to 7.87; p = 0.014), and LAVI >40 ml/m2 (hazard ratio: 3.32; 95% CI: 1.08 to 10.16; p = 0.036).

Conclusions

In HCM, peak cardiac index is the main determinant of exercise capacity, but it is not significantly related to ventilatory efficiency. Peak Vo2, ventilatory inefficiency, and LAVI are associated with an increased risk of major events in the short-term follow-up.

Key Words

cardiopulmonary test
echocardiography
heart failure
hypertrophic cardiomyopathy

Abbreviations and Acronyms

CI
confidence interval
CPET
cardiopulmonary exercise test
E/E'
early diastolic velocity ratio
HCM
hypertrophic cardiomyopathy
HR
heart rate
LV
left ventricular
LVEF
left ventricular ejection fraction
LVOT
left ventricular outflow tract
RV
right ventricle
VE/Vco2
ventilation/carbon dioxide output
Vo2
oxygen uptake

Cited by (0)

Stanford Cardiovascular Institute and Biotronik Italia funded the research. Dr. Magavern is funded by the Sarnoff Cardiovascular Research Foundations. Dr. Ashley is the co-founder of and owns stock options in Personalis, Inc. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.